Nifty
Sensex
:
:
10642.55
35367.36
25.85 (0.24%)
106.82 (0.30%)

Pharmaceuticals & Drugs

Rating :
47/99

BSE: 532649 | NSE: NECLIFE

21.80
-0.55 (-2.46%)
16-Nov-2018 | 2:44PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  22.15
  •  22.60
  •  21.75
  •  22.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  127703
  •  27.84
  •  41.70
  •  17.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 501.22
  • 9.12
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,446.97
  • 0.22%
  • 0.47

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.80%
  • 18.38%
  • 19.79%
  • FII
  • DII
  • Others
  • 0.1%
  • 0.00%
  • 5.93%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.00
  • 4.77
  • 7.25

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.40
  • -3.89
  • -0.23

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.45
  • -3.43
  • -1.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.82
  • 12.35
  • 13.45

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.69
  • 0.76
  • 0.77

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.48
  • 5.97
  • 6.42

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
-
2,068.66
1,643.70
1,675.69
1,643.64
1,638.31
1,626.25
1,313.11
1,062.06
845.80
727.97
Net Sales Growth
-
25.85%
-1.91%
1.95%
0.33%
0.74%
23.85%
23.64%
25.57%
16.19%
 
Cost Of Goods Sold
-
1,367.01
1,154.31
1,174.12
1,141.33
1,154.68
1,142.12
906.71
711.07
544.31
485.98
Gross Profit
-
701.65
489.39
501.57
502.31
483.63
484.13
406.40
350.99
301.49
241.98
GP Margin
-
33.92%
29.77%
29.93%
30.56%
29.52%
29.77%
30.95%
33.05%
35.65%
33.24%
Total Expenditure
-
1,832.51
1,419.29
1,436.94
1,376.73
1,350.44
1,336.10
1,064.59
834.89
650.85
590.13
Power & Fuel Cost
-
91.85
75.44
87.89
79.60
66.10
60.94
41.89
33.95
28.92
27.60
% Of Sales
-
4.44%
4.59%
5.25%
4.84%
4.03%
3.75%
3.19%
3.20%
3.42%
3.79%
Employee Cost
-
74.65
75.54
78.38
58.93
47.97
45.64
43.94
33.79
28.96
26.09
% Of Sales
-
3.61%
4.60%
4.68%
3.59%
2.93%
2.81%
3.35%
3.18%
3.42%
3.58%
Manufacturing Exp.
-
52.90
53.32
39.56
37.05
33.57
34.04
29.74
23.92
12.73
10.43
% Of Sales
-
2.56%
3.24%
2.36%
2.25%
2.05%
2.09%
2.26%
2.25%
1.51%
1.43%
General & Admin Exp.
-
23.02
20.07
20.36
21.60
22.03
18.43
17.17
13.13
17.72
17.01
% Of Sales
-
1.11%
1.22%
1.22%
1.31%
1.34%
1.13%
1.31%
1.24%
2.10%
2.34%
Selling & Distn. Exp.
-
221.12
39.00
35.24
35.25
24.71
29.84
18.48
14.84
14.41
15.51
% Of Sales
-
10.69%
2.37%
2.10%
2.14%
1.51%
1.83%
1.41%
1.40%
1.70%
2.13%
Miscellaneous Exp.
-
1.95
1.61
1.41
2.97
1.38
5.09
6.66
4.19
3.79
15.51
% Of Sales
-
0.09%
0.10%
0.08%
0.18%
0.08%
0.31%
0.51%
0.39%
0.45%
1.03%
EBITDA
-
236.15
224.41
238.75
266.91
287.87
290.15
248.52
227.17
194.95
137.84
EBITDA Margin
-
11.42%
13.65%
14.25%
16.24%
17.57%
17.84%
18.93%
21.39%
23.05%
18.93%
Other Income
-
6.04
22.67
5.78
20.00
12.53
16.04
12.89
13.46
19.40
6.24
Interest
-
115.20
117.41
123.31
125.59
137.99
115.49
115.25
74.09
60.30
49.62
Depreciation
-
64.31
62.25
57.39
76.56
84.19
75.96
60.73
46.10
38.75
30.31
PBT
-
62.68
67.42
63.83
84.75
78.23
114.75
85.43
120.44
115.30
64.16
Tax
-
10.41
12.08
9.59
18.49
16.14
29.01
12.22
16.24
23.01
11.19
Tax Rate
-
16.61%
17.92%
15.02%
21.82%
20.63%
25.28%
14.30%
13.48%
19.96%
17.44%
PAT
-
52.27
55.34
54.24
66.26
62.09
85.74
73.22
104.20
92.29
52.97
PAT before Minority Interest
-
52.27
55.34
54.24
66.26
62.09
85.74
73.22
104.20
92.29
52.97
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
2.53%
3.37%
3.24%
4.03%
3.79%
5.27%
5.58%
9.81%
10.91%
7.28%
PAT Growth
-
-5.55%
2.03%
-18.14%
6.72%
-27.58%
17.10%
-29.73%
12.90%
74.23%
 
Unadjusted EPS
-
2.33
2.47
2.42
2.95
2.77
3.82
3.26
4.65
5.83
3.47

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
1,058.66
1,006.68
954.08
957.95
927.06
867.60
784.46
721.13
620.65
303.35
Share Capital
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
15.23
Total Reserves
1,036.23
984.25
931.65
935.52
904.64
845.17
762.04
698.71
598.22
288.13
Non-Current Liabilities
355.84
295.58
362.30
396.92
340.94
361.54
432.02
288.67
651.08
744.53
Secured Loans
218.21
161.20
243.44
264.36
222.59
260.48
362.93
233.60
451.02
502.23
Unsecured Loans
1.87
2.60
1.96
1.17
0.75
0.48
0.69
0.74
149.88
202.11
Long Term Provisions
9.07
8.49
6.91
6.01
4.90
3.79
3.43
2.41
0.00
0.00
Current Liabilities
1,309.32
1,278.66
1,239.95
1,155.60
1,126.07
1,044.90
904.38
802.79
208.76
237.72
Trade Payables
539.42
528.10
496.78
455.58
440.06
382.52
194.49
139.83
134.52
175.33
Other Current Liabilities
123.40
106.88
107.95
90.50
86.72
131.28
129.87
245.93
9.28
8.36
Short Term Borrowings
634.08
630.34
627.24
595.30
579.84
509.11
565.21
330.01
0.00
0.00
Short Term Provisions
12.41
13.34
7.98
14.22
19.45
22.00
14.81
87.02
64.96
54.03
Total Liabilities
2,723.82
2,580.92
2,556.33
2,510.47
2,394.07
2,274.04
2,120.86
1,812.59
1,480.49
1,285.60
Net Block
852.35
881.24
905.58
933.73
947.54
913.84
857.87
736.26
627.26
525.94
Gross Block
1,381.56
1,363.67
1,383.66
1,451.42
1,341.15
1,223.31
1,091.46
909.26
754.17
614.44
Accumulated Depreciation
529.20
482.43
478.08
517.69
393.61
309.47
233.59
173.00
126.91
88.50
Non Current Assets
1,063.21
1,085.05
1,091.92
1,105.54
1,156.72
1,122.94
1,071.18
868.56
682.51
598.88
Capital Work in Progress
99.79
102.11
99.35
91.31
122.26
138.57
150.13
82.42
55.51
74.03
Non Current Investment
0.27
0.27
0.27
0.15
0.05
0.05
0.05
0.05
-0.26
-1.09
Long Term Loans & Adv.
104.19
96.90
82.24
80.34
86.87
70.48
63.12
49.84
0.00
0.00
Other Non Current Assets
6.61
4.53
4.47
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,660.61
1,495.86
1,464.42
1,369.02
1,237.34
1,151.08
1,049.67
944.00
797.94
686.39
Current Investments
0.51
0.41
0.52
0.44
0.31
0.32
0.14
5.33
21.32
2.07
Inventories
859.43
854.65
836.71
790.98
758.43
676.00
591.42
470.88
396.35
349.62
Sundry Debtors
611.97
499.73
491.45
446.50
376.65
349.39
304.49
311.13
222.46
167.26
Cash & Bank
9.31
13.18
36.65
33.38
9.98
6.24
25.93
32.58
34.79
34.47
Other Current Assets
179.38
53.88
31.54
13.12
91.97
119.13
127.70
124.08
123.02
132.96
Short Term Loans & Adv.
124.56
74.01
67.55
84.61
69.02
86.84
105.05
102.03
96.55
100.81
Net Current Assets
351.29
217.20
224.47
213.42
111.27
106.18
145.29
141.21
589.18
448.67
Total Assets
2,723.82
2,580.91
2,556.34
2,510.47
2,394.07
2,274.04
2,120.87
1,812.59
1,480.49
1,285.61

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
65.17
198.76
168.82
144.41
254.87
360.83
164.96
43.81
55.31
131.71
PBT
62.68
67.42
64.74
84.75
78.22
114.75
85.43
120.44
115.30
64.16
Adjustment
175.82
158.85
174.16
185.24
212.94
179.63
156.84
122.10
84.05
77.34
Changes in Working Capital
-160.72
-20.34
-61.52
-119.29
-16.31
68.28
-64.33
-186.05
-131.53
0.52
Cash after chg. in Working capital
77.79
205.93
177.38
150.70
274.85
362.66
177.94
56.48
67.81
142.03
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-12.62
-7.17
-8.56
-6.29
-19.98
-1.83
-12.98
-12.67
-12.50
-10.31
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-29.43
-18.10
-76.88
-59.53
-89.99
-98.95
-233.56
-168.65
-145.57
-181.55
Net Fixed Assets
-15.57
17.23
59.72
-79.32
-101.53
-120.29
-249.91
-182.00
-121.21
-210.57
Net Investments
-0.10
0.11
-0.53
-0.23
0.01
-0.18
5.19
20.32
-20.09
1.00
Others
-13.76
-35.44
-136.07
20.02
11.53
21.52
11.16
-6.97
-4.27
28.02
Cash from Financing Activity
-39.60
-204.12
-88.68
-61.47
-161.14
-281.56
61.95
122.63
90.57
58.28
Net Cash Inflow / Outflow
-3.87
-23.47
3.27
23.40
3.74
-19.68
-6.65
-2.21
0.32
8.44
Opening Cash & Equivalents
13.18
36.65
33.38
9.98
6.24
25.93
32.58
34.79
34.47
26.03
Closing Cash & Equivalent
9.31
13.18
36.65
33.38
9.98
6.24
25.93
32.58
34.79
34.47

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
47.21
44.89
42.54
41.11
41.34
38.69
34.98
32.15
27.67
19.90
ROA
1.97%
2.15%
2.14%
2.70%
2.66%
3.90%
3.72%
6.33%
6.67%
4.74%
ROE
5.06%
5.64%
5.78%
7.17%
6.92%
10.38%
9.73%
15.53%
19.98%
18.07%
ROCE
9.13%
9.73%
9.95%
11.58%
12.24%
12.88%
12.00%
14.21%
15.76%
12.82%
Fixed Asset Turnover
1.52
1.27
1.26
1.25
1.33
1.45
1.35
1.35
1.29
1.50
Receivable days
96.93
103.72
95.49
85.98
77.54
71.26
83.13
86.76
80.29
76.46
Inventory Days
149.46
176.99
165.71
161.85
153.20
138.12
143.44
141.01
153.69
128.53
Payable days
102.40
128.03
119.13
113.39
105.76
76.22
54.56
55.61
85.15
84.62
Cash Conversion Cycle
143.99
152.69
142.07
134.44
124.98
133.15
172.00
172.16
148.82
120.36
Total Debt/Equity
0.90
0.87
1.01
1.00
0.93
1.01
1.33
1.10
0.97
2.32
Interest Cover
1.54
1.57
1.52
1.67
1.57
1.99
1.74
2.63
2.91
2.29

News Update:


  • National Green Tribunal allows Nectar Lifesciences to start function of Derabassi Unit
    14th Nov 2018, 11:14 AM

    National Green Tribunal observed that the Unit II of the company is compliant of Environment Laws

    Read More
  • Nectar Lifesciences gets closure order for Derabassi Unit
    29th Oct 2018, 11:03 AM

    The inspections report of the CPCB sought by National Green Tribunal states that the company's unit is complying with pollution norms

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.